AVAH 241115 10.00P (AVAH241115P10000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

AVAH241115P10000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 8 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

UBS Adjusts Price Target on Aveanna Healthcare to $3.20 From $2.80, Maintains Sell Rating
MT Newswires11:16 ET · Ratings
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Catapults 25% Though Its Price And Business Still Lag The Industry
Simply Wall StNov 8 07:27 ET
Express News | Aveanna Healthcare Holdings Inc : Stephens Raises Target Price to $5.50 From $4
ReutersNov 8 06:55 ET
Deutsche Bank Maintains Aveanna Healthcare(AVAH.US) With Buy Rating, Raises Target Price to $7
Moomoo NewsNov 8 05:37 ET · Ratings
Aveanna Healthcare Reports Strong Q3 2024 Results
TipRanksNov 8 00:52 ET
Express News | Aveanna Healthcare Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Issued FY24 Sales Guidance Above Estimates
BenzingaNov 7 12:15 ET

Comments

Bigmoney Dreamer

Oct 15 18:59

$Aveanna Healthcare (AVAH.US)$ testing

Bigmoney Dreamer

Oct 9 19:46

$Aveanna Healthcare (AVAH.US)$

Tonyco

Oct 6 12:11

Columns Cause and Effect

Oh, no, numbers did a thing!!!! PAN8C SELL
Anticipating rate cuts in September, businesses increased payrolls by re-hiring all the people they laid off earlier in the year or later to "protect margins."
Why wouldn't you try to get a head start on boosted demand for products?
Predictably, Old Money doesn't think past the week, so if nothing else, next week, will present entry points.
$ChromaDex (CDXC.US)$ Bioscience, aging products.
FY24 Estimates:
Sales growth +13% yoy
Gross marg...

September new jobs higher than expected, is this a 'soft landing' ?

Tonyco

Oct 5 22:23

$Aveanna Healthcare (AVAH.US)$
Estimates for FY24:
Sales growth : +5% YoY
EBITDA: +16% YoY
Net Income : +106% YoY
EPS + 104% YoY

Moomoo AI

Dec 13, 2023 04:40

Despite Aveanna Healthcare's recent rally, its P/S ratio remains low amid predictions its growth will lag industry standards. This suggests investor expectation of limited future growth and a reluctance to pay more for its current state, likely averting a substantial price rise soon.

Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Price Is Right But Growth Is Lacking After Shares Rocket 46%